| NK cells converge lytic granules to promote cytotoxicity and prevent bystander killing HT Hsu, EM Mace, AF Carisey, DI Viswanath, AE Christakou, M Wiklund, ... Journal of Cell Biology 215 (6), 875-889, 2016 | 111 | 2016 |
| Potentiating antitumor efficacy through radiation and sustained intratumoral delivery of anti-CD40 and anti-PDL1 HC Liu, DI Viswanath, F Pesaresi, Y Xu, L Zhang, N Di Trani, ... International Journal of Radiation Oncology* Biology* Physics 110 (2), 492-506, 2021 | 59 | 2021 |
| Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines DI Viswanath, HC Liu, DP Huston, CYX Chua, A Grattoni Biomaterials 280, 121297, 2022 | 50 | 2022 |
| Sustained intratumoral administration of agonist CD40 antibody overcomes immunosuppressive tumor microenvironment in pancreatic cancer HC Liu, D Davila Gonzalez, DI Viswanath, RS Vander Pol, SZ Saunders, ... Advanced Science 10 (9), 2206873, 2023 | 30 | 2023 |
| Quantification of natural killer cell polarization and visualization of synaptic granule externalization by imaging flow cytometry DI Viswanath, EM Mace, HT Hsu, JS Orange Clinical Immunology 177, 70-75, 2017 | 16 | 2017 |
| Engineered implantable vaccine platform for continuous antigen-specific immunomodulation DI Viswanath, HC Liu, S Capuani, RS Vander Pol, SZ Saunders, ... Biomaterials 281, 121374, 2022 | 14 | 2022 |
| Long-acting tunable release of amlodipine loaded PEG-PCL micelles for tailored treatment of chronic hypertension N Di Trani, HC Liu, R Qi, DI Viswanath, X Liu, CYX Chua, A Grattoni Nanomedicine: Nanotechnology, Biology and Medicine 37, 102417, 2021 | 14 | 2021 |
| Intratumoral nanofluidic system enhanced tumor biodistribution of PD‐L1 antibody in triple‐negative breast cancer HC Liu, S Capuani, AA Badachhape, N Di Trani, D Davila Gonzalez, ... Bioengineering & Translational Medicine 8 (6), e10594, 2023 | 4 | 2023 |
| Engineering platforms for localized long-acting immune modulation. CYX Chua, DI Viswanath, DP Huston, A Grattoni Journal of Allergy and Clinical Immunology, 2024 | 2 | 2024 |
| Sustained Intratumoral Administration of Agonist CD40 Antibody Overcomes Immunosuppressive Tumor Microenvironment in Pancreatic Cancer (Adv. Sci. 9/2023) HC Liu, DD Gonzalez, DI Viswanath, RS Vander Pol, SZ Saunders, ... Advanced Science 10 (9), 2023 | 2 | 2023 |
| 83 Immunotherapy eluting intratumoral nanoseed achieves local and systemic tumor control of pancreatic cancer HC Liu, DD Gonzalez, R Vander Pol, D Viswanath, S Saunders, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 1 | 2022 |
| 759 Development of an implantable artificial lymph node as a therapeutic cancer vaccine D Viswanath, L Hsuan-Chen, CYX Chua, A Grattoni Journal for ImmunoTherapy of Cancer 8 (Suppl 3), A455-A455, 2020 | 1 | 2020 |
| Prophylactic and therapeutic cancer vaccine with continuous localized immunomodulation N Kota, DD Gonzalez, HC Liu, D Viswanath, R Vander Pol, A Wood, ... Nanomedicine: Nanotechnology, Biology and Medicine 62, 102776, 2024 | | 2024 |
| 757 Intratumoral delivery CD40 agonist antibody via novel nanofluidic drug-eluting seed reduced tumor burden of murine pancreatic ductal adenocarcinoma HC Liu, D Viswanath, R Vander Pol, C Chua, A Grattoni Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
| Lytic granule convergence is essential for NK cells to promote targeted killing while preventing collateral damage HT Hsu, D Viswanath, E Mace, A Christakou, M Wiklund, B Önfelt, ... The Journal of Immunology 196 (1_Supplement), 131.6-131.6, 2016 | | 2016 |
